Synedgen
Claremont, CA, United StatesFounded 2009Industry
Synedgen develops therapeutics including one for acute radiation syndrome. CBRNE-relevant work is a notable product line according to its website. It is headquartered in Claremont, CA, United States.
What it does
Threats covered
Profile
Synedgen, Inc. is a Claremont, California biotechnology company developing MIIST305, an oral, gut-restricted glycopolymer therapy for ulcerative colitis and for gastrointestinal acute radiation syndrome.
More profile
It was formed in 2009 through the merger of BioSTAR West and Hawaii Chitopure, and BioSTAR West itself began in 2005. In October 2024 the Biomedical Advanced Research and Development Authority awarded it a contract worth up to 119 million dollars to develop MIIST305 as a countermeasure for gastrointestinal acute radiation syndrome, and the contract's potential end date was extended to 22 December 2031.
In 2025 the US National Institutes of Health awarded 595,009 dollars for minipig radiation injury studies and biomarker development. A Los Angeles business newspaper has reported on the company's growth.
Ownership and investors were not found.
Ownership
Privately held; ownership not read
Parent: none identified
Sources (5)
- https://www.crunchbase.com/organization/synedgen
- https://www.synedgen.com/synedgen-barda-miist305/
- https://www.highergov.com/contract/75A50124C00047/
- https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=U01AI187042&arg_ProgOfficeCode=104
- https://labusinessjournal.com/news/weekly-news/medical-center-likes-prognosis-l-growth/
Not verified or not found
- Ownership and investors: not found.
- Clinical stage of MIIST305 for acute radiation syndrome: not read.
- Contract ceiling is the maximum, not funds committed.
Questions
What does Synedgen do?
Synedgen develops therapeutics including one for acute radiation syndrome. CBRNE-relevant work is a notable product line according to its website.
Where is Synedgen based?
HQ (as found): Claremont, CA. HQ country: US.
Who owns Synedgen?
Privately held; ownership not read. Parent: none identified
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction